VVZ-3416

N/A

Report date: 2023/10/16 11:36:00
NME

Base Information

Drug NameVVZ-3416
Drug Alias NameVVZ-3416
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNerve DegenerationParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVivozon Inc
China Registration ClassN/A

Develop Information

Active CompaniesVivozon Inc
Inactive CompaniesN/A
Active IndicationsNerve DegenerationParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A